Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|March 1, 2021
Erratum to: Combination Therapy in Pulmonary Arterial Hypertension: Gleaning a Practical Approach from the Randomized TrialsDavid C Booth
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|August 7, 2019
Combination Therapy in Pulmonary Arterial Hypertension: Gleaning a Practical Approach from the Randomized TrialsDavid C Booth
The Annals of Thoracic Surgery|January 23, 2013
Successful ventricular assist device placement in transposition of the great arteries with pulmonary hypertensionNavin Rajagopalan, David C Booth, Enrique Diaz-Guzman, et al.
JACC. Case Reports|June 20, 2026
Sotatercept in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension and Eisenmenger Syndrome: First Case SeriesGillian P Leung, Elaine C Major, Sydney C Cason, et al.
The Journal of Invasive Cardiology|September 7, 2006
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularizationPranab Das, David J Moliterno, Richard Charnigo, et al.
Circulation. Heart Failure|January 14, 2022
Ratio of Mixed Venous Oxygen Saturation-to-Pulmonary Capillary Wedge Pressure: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramDustin Hillerson, Richard Charnigo, Sun Moon Kim, et al.
Circulation. Cardiovascular Quality and Outcomes|July 29, 2010
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?Bernard R Chaitman, Pamela M Hartigan, David C Booth, et al.
American Heart Journal|September 11, 2013
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation TrialG B John Mancini, Pamela M Hartigan, Eric R Bates, et al.
JACC. Cardiovascular Interventions|January 21, 2014
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemiaG B John Mancini, Pamela M Hartigan, Leslee J Shaw, et al.
American Heart Journal|February 28, 2016
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trialSubroto Acharjee, Koon K Teo, Alice K Jacobs, et al.
Pageof 2